These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29033567)

  • 1. Nanoparticles for the treatment of liver fibrosis.
    Poilil Surendran S; George Thomas R; Moon MJ; Jeong YY
    Int J Nanomedicine; 2017; 12():6997-7006. PubMed ID: 29033567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology applications for the therapy of liver fibrosis.
    Giannitrapani L; Soresi M; Bondì ML; Montalto G; Cervello M
    World J Gastroenterol; 2014 Jun; 20(23):7242-51. PubMed ID: 24966595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis.
    Jia Z; Gong Y; Pi Y; Liu X; Gao L; Kang L; Wang J; Yang F; Tang J; Lu W; Li Q; Zhang W; Yan Z; Yu L
    Mol Pharm; 2018 Jan; 15(1):53-62. PubMed ID: 29148802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells.
    Zhang C; Teng Y; Li F; Ho W; Bai X; Xu X; Zhang XQ
    ACS Nano; 2023 Aug; 17(15):14852-14870. PubMed ID: 37490628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
    Thomas RG; Moon MJ; Kim JH; Lee JH; Jeong YY
    PLoS One; 2015; 10(12):e0145512. PubMed ID: 26714035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of HGF carried by ultrasound microbubble-cationic nano-liposomes complex for treating hepatic fibrosis in a bile duct ligation rat model, and its relationship with the diffusion-weighted MRI parameters.
    Zhang SH; Wen KM; Wu W; Li WY; Zhao JN
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):602-7. PubMed ID: 24012221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy.
    Zhang Z; Wang C; Zha Y; Hu W; Gao Z; Zang Y; Chen J; Zhang J; Dong L
    ACS Nano; 2015 Mar; 9(3):2405-19. PubMed ID: 25587629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers.
    Balaji A; Bell CA; Houston ZH; Bridle KR; Genz B; Fletcher NL; Ramm GA; Thurecht KJ
    Biomaterials; 2023 Nov; 302():122318. PubMed ID: 37708659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy.
    Omar R; Yang J; Liu H; Davies NM; Gong Y
    Rev Physiol Biochem Pharmacol; 2016; 172():1-37. PubMed ID: 27534415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
    Hassan R; Tammam SN; Safy SE; Abdel-Halim M; Asimakopoulou A; Weiskirchen R; Mansour S
    Eur J Pharm Biopharm; 2019 Jan; 134():96-106. PubMed ID: 30471341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
    Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
    Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review.
    Zhou L; Li Y; Liang Q; Liu J; Liu Y
    J Drug Target; 2022 Jul; 30(6):577-588. PubMed ID: 35179094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting.
    El-Safy S; Tammam SN; Abdel-Halim M; Ali ME; Youshia J; Shetab Boushehri MA; Lamprecht A; Mansour S
    Eur J Pharm Biopharm; 2020 Mar; 148():54-66. PubMed ID: 31945489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.
    Zhang F; Kong D; Lu Y; Zheng S
    Cell Mol Life Sci; 2013 Jan; 70(2):259-76. PubMed ID: 22699820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications.
    Talwalkar JA; Yin M; Fidler JL; Sanderson SO; Kamath PS; Ehman RL
    Hepatology; 2008 Jan; 47(1):332-42. PubMed ID: 18161879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
    Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
    Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
    El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
    J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inorganic nanoparticles on liver fibrosis: Optimizing a double-edged sword for therapeutics.
    Tee JK; Peng F; Ho HK
    Biochem Pharmacol; 2019 Feb; 160():24-33. PubMed ID: 30529191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis.
    Peng W; Cheng S; Bao Z; Wang Y; Zhou W; Wang J; Yang Q; Chen C; Wang W
    Biomed Pharmacother; 2021 May; 137():111342. PubMed ID: 33581652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis.
    Chen Z; Jain A; Liu H; Zhao Z; Cheng K
    J Pharmacol Exp Ther; 2019 Sep; 370(3):695-702. PubMed ID: 30886124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.